News

Lung cancer can co-opt genes that normally help a fetus develop and evade the mother's immune system. And while these ...
The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...
Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...
The American Lung Association is kicking off Lung Cancer Action Week on Monday to promote screenings for lung cancer. As part of the effort, the association will offer free lung cancer screenings in ...
Small-cell lung cancer (SCLC) is one of the most aggressive and deadly types of cancer, often linked to smoking. Although it ...
A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear.
Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...
Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...
Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access.
Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...